News
Progress from CortiAura
21 October 2026
CortiAura receives HMRC advance assurance for SEIS and EIS
HMRC has given Dacpras Ltd, the company behind CortiAura, advance assurance for the Seed Enterprise Investment Scheme (SEIS) and the Enterprise Investment Scheme (EIS), based on the information we supplied. Advance assurance is not an endorsement of the company or a guarantee of tax relief for any investor.
5 October 2026
CortiAura ranked in the top 15% for the Cambridge NeuroWorks Blue Sky Proof-of-Concept Fund
Our proposal to the Blue Sky Proof-of-Concept Fund, a UK-wide initiative run by Cambridge NeuroWorks in partnership with ARIA (the UK government’s Advanced Research and Invention Agency), was ranked in the top 15% of applications. This ranking relates to our application only and is not funding or endorsement by Cambridge NeuroWorks or ARIA.
5 October 2026
Founding Community now open
Join for free to follow our progress, with priority access and a founding-member discount at launch.
5 October 2026
Early safety and feasibility study in design
We are building partnerships with clinical and academic collaborators to take the study forward.
5 October 2026
Prototype development underway
An experienced UK medical device engineering team is helping take CortiAura from concept to working prototype.